Salmeterol/Fluticasone Propionate via Diskus™ Once Daily versus Fluticasone Propionate Twice Daily in Patients with Mild Asthma not Previously Receiving Maintenance Corticosteroids

被引：0
|
作者：
Alexander Chuchalin
Loretta Jacques
Lucy Frith
机构：
[1] Pulmonology Research Institute,
[2] GlaxoSmithKline Research and Development Limited,undefined
[3] Russian Research Institute of Pulmonology,undefined
来源：
Clinical Drug Investigation | 2008年 / 28卷
关键词：
Asthma; Fluticasone Propionate; Salmeterol; Peak Expiratory Flow; Mometasone Furoate;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：169 / 181
页数：12
相关论文
共 50 条
  • [21] Adding salmeterol to fluticasone propionate or increasing the dose of fluticasone propionate in patients with asthma
    Delea, Thomas E.
    Hagiwara, May
    Stempel, David A.
    Stanford, Richard H.
    ALLERGY AND ASTHMA PROCEEDINGS, 2010, 31 (03) : 211 - 218
  • [22] Combined salmeterol/fluticasone propionate versus fluticasone propionate alone in mild asthma: A placebo-controlled comparison
    Boonsawat, Watchara
    Goryachkina, Ludmila
    Jacques, Loretta
    Frith, Lucy
    CLINICAL DRUG INVESTIGATION, 2008, 28 (02) : 101 - 111
  • [23] Once-daily fluticasone propionate is as effective as twice-daily treatment in stable, mild-to-moderate childhood asthma
    Hodges, IGC
    Netherway, TA
    CLINICAL DRUG INVESTIGATION, 2005, 25 (01) : 13 - 22
  • [24] Once-Daily Fluticasone Propionate is as Effective as Twice-Daily Treatment in Stable, Mild-to-Moderate Childhood Asthma
    Ian G. C. Hodges
    Thelma A. Netherway
    Clinical Drug Investigation, 2005, 25 : 13 - 22
  • [25] Steroid-sparing effects of fluticasone propionate 100 μg and salmeterol 50 μg administered twice daily in a single product in patients previously controlled with fluticasone propionate 250 μg administered twice daily
    Busse, W
    Koenig, SM
    Oppenheimer, J
    Sahn, SA
    Yancey, SW
    Reilly, D
    Edwards, LD
    Dorinsky, PM
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2003, 111 (01) : 57 - 65
  • [26] Long-term Treatment with Fluticasone propionate (FP) and Salmeterol via DISKUS® (FSC) Improves Asthma Control versus Fluticasone propionate (FP) Alone
    Katial, R.
    Bernstein, D.
    Prazma, C.
    Lincourt, W.
    Stempel, D.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2010, 181
  • [27] Combination of salmeterol/fluticasone propionate via Diskus® improves quality of life in asthma patients.
    Reese, PR
    Mather, DB
    Mahajan, P
    Woodring, A
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1999, 103 (01) : S69 - S69
  • [28] A comparison of the efficacy and safety of once-daily fluticasone furoate/vilanterol with twice-daily fluticasone propionate/salmeterol in moderate to very severe COPD
    Agusti, Alvar
    de Teresa, Luis
    De Backer, Wilfried
    Zvarich, Michael T.
    Locantore, Nicholas
    Barnes, Neil
    Bourbeau, Jean
    Crim, Courtney
    EUROPEAN RESPIRATORY JOURNAL, 2014, 43 (03) : 763 - 772
  • [29] Efficacy and safety of once-daily fluticasone furoate/vilanterol (100/25 mcg) versus twice-daily fluticasone propionate/salmeterol (250/50 mcg) in COPD patients
    Dransfield, Mark T.
    Feldman, Gregory
    Korenblat, Phillip
    LaForce, Craig F.
    Locantore, Nicholas
    Pistolesi, Massimo
    Watkins, Michael L.
    Crim, Courtney
    Martinez, Fernando J.
    RESPIRATORY MEDICINE, 2014, 108 (08) : 1171 - 1179
  • [30] The efficacy of fluticasone propionate diskus (Flovent Diskus™) is equally maintained whether administered once or twice daily over one YEar in the treatment of moderate asthma
    Faris, M
    Wire, P
    Duke, S
    Harding, S
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2000, 105 (01) : S13 - S13
12345